Price Chart
Key Statistics
Previous Close
$31.38Day Range
52-Week Range
Avg Volume
12.6KDividend Yield
1.27%Expense Ratio
0.59%AUM
$52.3MShares Outstanding
1.3METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 44.55% |
| Denmark | 19.75% |
| China | 16.42% |
| Japan | 4.66% |
| Switzerland | 3.93% |
| United Kingdom | 3.66% |
| South Korea | 3.58% |
| Hong Kong | 2.29% |
| Other | 0.71% |
| Singapore | 0.46% |
Fund Information
- Issuer
- Roundhill Investments
- Category
- Healthcare
- Types
- Pharma
- Inception Date
- May 21, 2024
- Exchange
- NASDAQ
- Description
- Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.
Similar ETFs
The Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund issued by Roundhill Investments that launched on May 21, 2024. It currently manages $52.3M in assets under management. The fund charges an expense ratio of 0.59%. The fund holds 29 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 67.1% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | 15.12% | 9,003 | $8.0M |
| 2 | NVO | Novo Nordisk A/S | 14.38% | 183,834 | $7.6M |
| 3 | PFE | Pfizer Inc | 7.10% | 138,419 | $3.7M |
| 4 | 1672.HK | Ascletis Pharma Inc | 5.26% | 1,133,000 | $2.8M |
| 5 | VKTX | Viking Therapeutics Inc | 5.20% | 83,569 | $2.7M |
| 6 | 1801.HK | Innovent Biologics Inc | 5.05% | 242,500 | $2.7M |
| 7 | ROP.SW | Roche Holding AG | 4.00% | 5,146 | $2.1M |
| 8 | AMGN | Amgen Inc | 3.77% | 5,762 | $2.0M |
| 9 | ZEAL.CO | Zealand Pharma A/S | 3.67% | 40,685 | $1.9M |
| 10 | 128940.KS | Hanmi Pharm Co Ltd | 3.56% | 5,593 | $1.9M |
| 11 | AZN | AstraZeneca PLC | 3.54% | 9,819 | $1.9M |
| 12 | 4519.T | Chugai Pharmaceutical Co Ltd | 3.46% | 32,800 | $1.8M |
| 13 | 2196.HK | Shanghai Fosun Pharmaceutical Group Co Ltd | 3.24% | 662,500 | $1.7M |
| 14 | REGN | Regeneron Pharmaceuticals Inc | 3.17% | 2,218 | $1.7M |
| 15 | 1093.HK | CSPC Pharmaceutical Group Ltd | 2.83% | 1,298,000 | $1.5M |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -1.25% | |
| 1W | -4.45% | |
| 1M | +1.90% | |
| 3M | -14.63% | |
| 6M | +9.57% | |
| YTD | -10.22% | |
| 1Y | +27.85% | |
| 3Y | +21.52% | |
| 5Y | +21.52% |
Moving Averages
$31.57
Below 20-Day MA$32.14
Below 50-Day MA$30.28
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$37.01
Current Price
$30.99
52-Week Low
$23.24
Current Yield
1.27%
Annual Dividend
$0.4630
Frequency
1x/year
Last Ex-Date
Dec 30, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 30, 2025 | $0.4099 | Dec 31, 2025 |
| Dec 30, 2024 | $0.0531 | Dec 31, 2024 |
Dividend Payments Over Time
Category Comparison
| Metric | OZEM | Healthcare(212 ETFs) | Pharma(29 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.59% | 0.61% | 0.66% |
| AUM | $52.3M | $1.20B | $1.45B |
| Dividend Yield | 1.27% | 3.25% | 1.82% |
| Avg Volume | 12.6K | 342.6K | 349.1K |
| Holdings | 29 | 181 | 42 |
| Performance | |||
| 1-Month Return | +1.91% | +6.30% | +3.16% |
| 6-Month Return | +12.07% | +6.13% | +11.64% |
| YTD Return | -9.74% | +2.71% | -0.60% |
| 1-Year Return | +27.23% | +28.23% | +35.06% |
Compare with Another ETF
Search for an ETF to compare with OZEM:
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.